Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

Pillars article: an unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J. Exp. Med. 1957. 105: 425-438.

Franklin EC, Holman HR, Müller-Eberhard HJ, Kunkel HG.

J Immunol. 2007 Feb 1;178(3):1229-42. No abstract available.

2.

Purification and characterization of a phagocytosis inducing factor: role in cell-substratum adherence.

Chakravarti B, Chakravarti DN, Müller-Eberhard HJ.

Biochem Biophys Res Commun. 1998 Feb 13;243(2):591-7.

PMID:
9480853
3.
4.
5.

Role of de novo protein synthesis by human mononuclear leukocytes in opsonin-independent phagocytosis.

Chakravarti B, Chakravarti DN, Müller-Eberhard HJ.

Cell Immunol. 1994 Mar;154(1):134-42.

PMID:
8118882
6.

The pore-forming peptide of Entamoeba histolytica, the protozoan parasite causing human amoebiasis.

Leippe M, Müller-Eberhard HJ.

Toxicology. 1994 Feb 28;87(1-3):5-18. Review.

PMID:
7512763
7.

Primary and secondary structure of the pore-forming peptide of pathogenic Entamoeba histolytica.

Leippe M, Tannich E, Nickel R, van der Goot G, Pattus F, Horstmann RD, Müller-Eberhard HJ.

EMBO J. 1992 Oct;11(10):3501-6.

8.

Channel-forming proteins of man and amoebae.

Müller-Eberhard HJ.

Behring Inst Mitt. 1992 Apr;(91):138-44. Review. No abstract available.

PMID:
1381916
9.

Pore-forming peptide of pathogenic Entamoeba histolytica.

Leippe M, Ebel S, Schoenberger OL, Horstmann RD, Müller-Eberhard HJ.

Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7659-63.

10.

Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement.

Zalman LS, Müller-Eberhard HJ.

Mol Immunol. 1990 Jun;27(6):533-7.

PMID:
1696352
11.
12.

Isolation of homologous restriction factor from human urine. Immunochemical properties and biologic activity.

Zalman LS, Brothers MA, Müller-Eberhard HJ.

J Immunol. 1989 Sep 15;143(6):1943-7.

PMID:
2476489
13.

Structural homology of complement protein C6 with other channel-forming proteins of complement.

Chakravarti DN, Chakravarti B, Parra CA, Muller-Eberhard HJ.

Proc Natl Acad Sci U S A. 1989 Apr;86(8):2799-803.

14.
16.

A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.

Lambris JD, Avila D, Becherer JD, Müller-Eberhard HJ.

J Biol Chem. 1988 Aug 25;263(24):12147-50.

17.

Self-protection of cytotoxic lymphocytes: a soluble form of homologous restriction factor in cytoplasmic granules.

Zalman LS, Brothers MA, Müller-Eberhard HJ.

Proc Natl Acad Sci U S A. 1988 Jul;85(13):4827-31.

18.
19.

The structure of human complement component C7 and the C5b-7 complex.

DiScipio RG, Chakravarti DN, Muller-Eberhard HJ, Fey GH.

J Biol Chem. 1988 Jan 5;263(1):549-60.

20.

Molecular organization and function of the complement system.

Müller-Eberhard HJ.

Annu Rev Biochem. 1988;57:321-47. Review. No abstract available.

PMID:
3052276
21.
22.

Expression and modulation of homologous restriction factor (HRF) on peripheral white blood cells.

Sayama K, Zalman LS, Müller-Eberhard HJ, Gigli I.

Trans Assoc Am Physicians. 1988;101:270-81. No abstract available.

PMID:
2855898
23.
24.

Regulation of the alternative pathway of human complement by C1q.

Fishelson Z, Müller-Eberhard HJ.

Mol Immunol. 1987 Sep;24(9):987-93.

PMID:
2958692
25.

Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3.

Jung G, Martin DE, Müller-Eberhard HJ.

J Immunol. 1987 Jul 15;139(2):639-44.

PMID:
3110277
26.
27.

Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates.

Jung G, Ledbetter JA, Müller-Eberhard HJ.

Proc Natl Acad Sci U S A. 1987 Jul;84(13):4611-5.

28.

Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes.

Müller-Eberhard HJ, Zalman LS, Chiu FJ, Jung G, Martin DE.

J Rheumatol Suppl. 1987 Jun;14 Suppl 13:28-34.

PMID:
3612651
29.

Regulation of the alternative pathway of complement by pH.

Fishelson Z, Horstmann RD, Müller-Eberhard HJ.

J Immunol. 1987 May 15;138(10):3392-5.

PMID:
2952717
31.
32.
33.

Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.

Zalman LS, Wood LM, Frank MM, Müller-Eberhard HJ.

J Exp Med. 1987 Feb 1;165(2):572-7.

34.

The multifunctional role of C3: structural analysis of its interactions with physiological ligands.

Lambris JD, Müller-Eberhard HJ.

Mol Immunol. 1986 Nov;23(11):1237-42. No abstract available.

PMID:
2950317
35.

Demonstration of C3b receptor-like activity and of decay-accelerating factor-like activity on rabbit erythrocytes.

Horstmann RD, Müller-Eberhard HJ.

Eur J Immunol. 1986 Sep;16(9):1069-73.

PMID:
2428623
36.
37.
38.
39.

Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates.

Jung G, Honsik CJ, Reisfeld RA, Müller-Eberhard HJ.

Proc Natl Acad Sci U S A. 1986 Jun;83(12):4479-83.

40.
41.

Structural analysis of the asparagine-linked oligosaccharides of human complement component C3.

Hirani S, Lambris JD, Müller-Eberhard HJ.

Biochem J. 1986 Jan 15;233(2):613-6.

42.

The membrane attack complex of complement.

Müller-Eberhard HJ.

Annu Rev Immunol. 1986;4:503-28. Review. No abstract available.

PMID:
3518749
43.

A C9 related channel forming protein in the cytoplasmic granules of human large granular lymphocytes.

Zalman LS, Brothers MA, Müller-Eberhard HJ.

Biosci Rep. 1985 Dec;5(12):1093-100.

PMID:
3830274
44.
45.

Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.

Tamerius JD, Pangburn MK, Müller-Eberhard HJ.

J Immunol. 1985 Sep;135(3):2015-9.

PMID:
2410510
46.

Complement C8 deficiency with recurrent meningococcemia: examination of meningococcal opsonization.

Kemp AS, Vernon J, Muller-Eberhard HJ, Bau DC.

Aust Paediatr J. 1985 Aug;21(3):169-71.

PMID:
4062713
47.

Self-association of the seventh component of human complement (C7): dimerization and polymerization.

Pressner KT, Podack ER, Müller-Eberhard HJ.

J Immunol. 1985 Jul;135(1):452-8.

PMID:
3998469
48.
49.

The killer molecule of complement.

Müller-Eberhard HJ.

J Invest Dermatol. 1985 Jul;85(1 Suppl):47s-52s. Review.

50.

Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.

Lambris JD, Ganu VS, Hirani S, Müller-Eberhard HJ.

Proc Natl Acad Sci U S A. 1985 Jun;82(12):4235-9.

Supplemental Content

Loading ...
Support Center